Vanguard’s Biggest Bond ETF Becomes First to Break $100 Billion
A bond exchange-traded fund crossed $100 billion for the first time since such products launched over two decades
2023-12-01 03:28
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:58
With Yields Above 5%, Some Investors Say It's Safe to Start Buying Bonds Again
Embattled debt investors like the look of 5% Treasury yields as they weigh the risk-versus-reward scales for the
2023-10-27 03:17
Biggest Treasury ETF Sees Largest Exodus Since 2020 Meltdown
Investors are bailing out of the biggest exchange-traded fund devoted to Treasuries at the fastest pace since markets
2023-08-15 01:49
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:29
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:20
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
2023-05-09 02:28